Evidence map›Paper›PMID 31780667›Full record

ArticleScientific reports2019

Production of recombinant soluble dimeric C-type lectin-like receptors of rat natural killer cells.

Ondřej Vaněk, Petra Celadova, Ondřej Skořepa, Jan Bláha, Barbora Kalousková, Anna Dvorská, Edita Poláchová, Helena Pucholtová, Daniel Kavan, Petr Pompach and 5 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Ondřej VaněkDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic. ondrej.vanek@natur.cuni.cz.ORCID http://orcid.org/0000-0003-1190-8535
Petra CeladovaDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
Ondřej SkořepaDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
Jan BláhaDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.ORCID http://orcid.org/0000-0003-4221-3162
Barbora KalouskováDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
Anna DvorskáDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
Edita PoláchováDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
Helena PucholtováDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
Daniel KavanDepartment of Biochemistry, Faculty of Science, Charles University, Hlavova 2030/8, 12840, Prague, Czech Republic.
Petr PompachInstitute of Microbiology, The Czech Academy of Sciences, Vídeňská 1083, 14220, Prague, Czech Republic.
Kateřina HofbauerováInstitute of Microbiology, The Czech Academy of Sciences, Vídeňská 1083, 14220, Prague, Czech Republic.ORCID http://orcid.org/0000-0001-7608-793X
Vladimír KopeckýInstitute of Physics, Faculty of Mathematics and Physics, Charles University, Ke Karlovu 5, 12116, Prague, Czech Republic.ORCID http://orcid.org/0000-0002-7331-9018
Aruz MesciDepartment of Immunology, University of Toronto, 1 King's College Circle, M5S 1A8, Toronto, ON, Canada.
Sebastian VoigtDepartment of Infectious Diseases, Robert Koch Institute, Seestraße 10, 13353, Berlin, Germany.ORCID http://orcid.org/0000-0003-1544-9903
James R CarlyleDepartment of Immunology, University of Toronto, 1 King's College Circle, M5S 1A8, Toronto, ON, Canada.
Charles University · CZCzech Academy of Sciences · CZUniversity of Toronto · CARobert Koch Institute · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Working at the border between innate and adaptive immunity, natural killer (NK) cells play a key role in the immune system by protecting healthy cells and by eliminating malignantly transformed, stressed or virally infected cells. NK cell recognition of a target cell is mediated by a receptor "zipper" consisting of various activating and inhibitory receptors, including C-type lectin-like receptors. Among this major group of receptors, two of the largest rodent receptor families are the NKR-P1 and the Clr receptor families. Although these families have been shown to encode receptor-ligand pairs involved in MHC-independent self-nonself discrimination and are a target for immune evasion by tumour cells and viruses, structural mechanisms of their mutual recognition remain less well characterized. Therefore, we developed a non-viral eukaryotic expression system based on transient transfection of suspension-adapted human embryonic kidney 293 cells to produce soluble native disulphide dimers of NK cell C-type lectin-like receptor ectodomains. The expression system was optimized using green fluorescent protein and secreted alkaline phosphatase, easily quantifiable markers of recombinant protein production. We describe an application of this approach to the recombinant protein production and characterization of native rat NKR-P1B and Clr-11 proteins suitable for further structural and functional studies.

Indexed as

AnimalsCalcitonin Receptor-Like ProteinHEK293 CellsHumansNK Cell Lectin-Like Receptor Subfamily BProtein DomainsProtein EngineeringProtein MultimerizationRatsRecombinant ProteinsCalcitonin Receptor-Like ProteinCalcrl protein, ratNK Cell Lectin-Like Receptor Subfamily BRecombinant Proteins

Identifiers

PMID31780667
PMCPMC6882821
OpenAlexW2990434737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.